Kaliumklorid Karo Healthcare

Potassium Chloride, the active ingredient in Kaliumklorid, is a potassium supplement presented as an oral electrolyte formulation for oral administration. It is used to restore normal potassium concentrations in the body, helping to correct hypokalemia and maintain cellular function in patients who require electrolyte replacement.

GNH USA supplies Kaliumklorid, sourced from the European Union, as a licensed, GDP‑compliant pharmaceutical product to hospitals, pharmacies and clinics worldwide. The company adheres to international quality standards and provides regulatory support for global distribution.

Kaliumklorid (potassium chloride) is employed in the management of conditions involving low potassium levels and related electrolyte disturbances.

- Hypokalemia: restores serum potassium to normal ranges, reducing symptoms such as muscle weakness and cardiac arrhythmias. - Potassium deficiency: supplies essential potassium ions to support cellular metabolism and nerve‑muscle function. - Cardiac arrhythmia risk reduction: helps maintain normal cardiac electrical activity by correcting electrolyte imbalance.

Potassium chloride may cause a range of adverse reactions, most of which are related to gastrointestinal irritation or electrolyte imbalance.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Vomiting: occasional expulsion of stomach contents. - Abdominal discomfort: cramping or pain in the stomach area. - Diarrhea: loose, watery stools. - Taste alteration: metallic or salty taste perception. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high serum potassium that can affect heart rhythm. - Cardiac arrhythmia: irregular heartbeats potentially leading to serious complications. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Hyperglycemia: elevated blood glucose levels in susceptible individuals.

When using Kaliumklorid, clinicians should consider several safety measures to minimize risk.

- Serum potassium monitoring: check levels before initiation and periodically during therapy. - Renal impairment adjustment: reduce dose or increase monitoring in patients with reduced kidney function. - Avoid in existing hyperkalemia: do not prescribe if serum potassium is already elevated. - Caution with ACE inhibitors/ARBs: these drugs may increase potassium levels and require closer observation. - Review concomitant potassium‑sparing diuretics: assess need for dose modification. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Potassium chloride can interact with several medications, affecting potassium balance or cardiac function.

Major Interactions (Avoid): - ACE inhibitors: may cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of excessive potassium. - NSAIDs: can reduce renal potassium excretion, raising serum levels.

Moderate Interactions (Monitor Closely): - Digoxin: elevated potassium may diminish digoxin toxicity but requires monitoring. - Lithium: altered renal handling may affect lithium concentrations.